Logo image of ALINV.PA

INVIBES ADVERTISING (ALINV.PA) Stock Fundamental Analysis

EPA:ALINV - Euronext Paris - Matif - BE0974299316 - Common Stock - Currency: EUR

0.982  +0.02 (+2.08%)

Fundamental Rating

2

Taking everything into account, ALINV scores 2 out of 10 in our fundamental rating. ALINV was compared to 63 industry peers in the Media industry. The financial health of ALINV is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ALINV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALINV has reported negative net income.
ALINV had a negative operating cash flow in the past year.
In multiple years ALINV reported negative net income over the last 5 years.
In multiple years ALINV reported negative operating cash flow during the last 5 years.
ALINV.PA Yearly Net Income VS EBIT VS OCF VS FCFALINV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -23.05%, ALINV is doing worse than 87.30% of the companies in the same industry.
The Return On Equity of ALINV (-42.76%) is worse than 79.37% of its industry peers.
Industry RankSector Rank
ROA -23.05%
ROE -42.76%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALINV.PA Yearly ROA, ROE, ROICALINV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALINV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALINV.PA Yearly Profit, Operating, Gross MarginsALINV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

ALINV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALINV has been increased compared to 1 year ago.
The number of shares outstanding for ALINV has been increased compared to 5 years ago.
Compared to 1 year ago, ALINV has an improved debt to assets ratio.
ALINV.PA Yearly Shares OutstandingALINV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 1M 2M 3M 4M
ALINV.PA Yearly Total Debt VS Total AssetsALINV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 0.50, we must say that ALINV is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.50, ALINV is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.11 indicates that ALINV is not too dependend on debt financing.
ALINV has a Debt to Equity ratio of 0.11. This is amongst the best in the industry. ALINV outperforms 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 0.5
ROIC/WACCN/A
WACC4.55%
ALINV.PA Yearly LT Debt VS Equity VS FCFALINV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

ALINV has a Current Ratio of 1.89. This is a normal value and indicates that ALINV is financially healthy and should not expect problems in meeting its short term obligations.
ALINV's Current ratio of 1.89 is amongst the best of the industry. ALINV outperforms 85.71% of its industry peers.
ALINV has a Quick Ratio of 1.89. This is a normal value and indicates that ALINV is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALINV (1.89) is better than 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.89
ALINV.PA Yearly Current Assets VS Current LiabilitesALINV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

The earnings per share for ALINV have decreased strongly by -1253.03% in the last year.
ALINV shows a decrease in Revenue. In the last year, the revenue decreased by -7.89%.
The Revenue has been growing by 22.39% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1253.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.57%
Revenue 1Y (TTM)-7.89%
Revenue growth 3Y4.7%
Revenue growth 5Y22.39%
Sales Q2Q%-10.61%

3.2 Future

ALINV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.73% yearly.
Based on estimates for the next years, ALINV will show a small growth in Revenue. The Revenue will grow by 2.97% on average per year.
EPS Next Y4.76%
EPS Next 2Y10.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.13%
Revenue Next 2Y2.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALINV.PA Yearly Revenue VS EstimatesALINV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
ALINV.PA Yearly EPS VS EstimatesALINV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8

0

4. Valuation

4.1 Price/Earnings Ratio

ALINV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALINV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALINV.PA Price Earnings VS Forward Price EarningsALINV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALINV.PA Per share dataALINV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.73%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALINV!.
Industry RankSector Rank
Dividend Yield N/A

INVIBES ADVERTISING

EPA:ALINV (8/8/2025, 7:00:00 PM)

0.982

+0.02 (+2.08%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.08%
Inst Owner ChangeN/A
Ins Owners18.63%
Ins Owner ChangeN/A
Market Cap4.49M
Analysts84.44
Price Target3.06 (211.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-21.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-6.43%
Revenue NY rev (3m)-6.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)-1.45
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS5.83
BVpS3.38
TBVpS2.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.05%
ROE -42.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.24%
Cap/Sales 8.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 1.89
Altman-Z 0.5
F-Score3
WACC4.55%
ROIC/WACCN/A
Cap/Depr(3y)99.71%
Cap/Depr(5y)148.63%
Cap/Sales(3y)8.58%
Cap/Sales(5y)10.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1253.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.57%
EPS Next Y4.76%
EPS Next 2Y10.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.89%
Revenue growth 3Y4.7%
Revenue growth 5Y22.39%
Sales Q2Q%-10.61%
Revenue Next Year-1.13%
Revenue Next 2Y2.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-585.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year72.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.17%
OCF growth 3YN/A
OCF growth 5YN/A